Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics
Sarah Allegra, Emma Dondi, Silvia De Francia
Abstract
1. Tyrosine kinase inhibitors (TKIs) are designed to specifically target tyrosine kinases that are overexpressed and/or mutated in cancer tissues. TKIs binding inhibits a number of cell activities,...
Topics & Concepts
PharmacogeneticsPharmacokineticsPharmacologyTyrosine kinaseMedicineBiologyReceptorInternal medicineGenotypeGeneticsGeneHER2/EGFR in Cancer ResearchChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research